Latest News

• share
• favorite_border

If you see something, it's because you're looking at it, right? A recently published study in ARVO's Journal of Vision examined this question and established that while people do tend to notice objects within their gaze, it is the assumptions they make about their environment that affects their perceptions. People are biased towards believing that they were looking directly at what they have seen.

• share
• favorite_border

The National Eye Institute (NEI) and the Food and Drug Administration (FDA) are sponsoring a symposium to consider new disease-relevant outcome measures appropriate for evaluating glaucoma therapies.

• share
• favorite_border

Scientists and the Food and Drug Administration (FDA) are discussing how new technologies in ophthalmology, which make it possible to collect better data about experimental treatments, might affect FDA clinical trials requirements.

• share
• favorite_border

Why is it difficult to spot even familiar faces in a crowd? A recent study in the Journal of Vision reveals how our brains filter out visual overload "” and could help scientists develop an artificial visual system that approaches the sophistication of human visual perception.

• share
• favorite_border

Visual field loss (specifically peripheral visual fields) is the primary vision component that increases the risk of falls, according to a study published this month in Investigative Ophthalmology and Vision Science. The authors say that people with visual field loss may benefit from mobility training to navigate the environment more safely.

• share
• favorite_border

A computer-based method for evaluating the eye's ability to distinguish object details and shape in patients with age-related macular degeneration (AMD) could provide a more accurate way to assess the effectiveness of eye surgery or other interventions, according to a Canadian study published in the October issue of ARVO's Investigative Ophthalmology and Vision Science.

• share
• favorite_border

The ARVO Foundation for Eye Research (AFER) announced today that it has received a $500,000 donation from the Allergan Foundation to sponsor a Clinical Trials Course Program which will launch a new education series. AFER is a supporting organization of the Association for Research in Vision and Ophthalmology (ARVO).

• share
• favorite_border

The ARVO Foundation for Eye Research, a supporting non-profit of the Association for Research in Vision and Ophthalmology (ARVO), today announced the recipients of the 2007 ARVO/Alcon Early Career Clinician-Scientist Research Awards. The awards will be presented on Sunday, May 6, during the ARVO/Alcon Keynote Session at the 2007 ARVO Annual Meeting in Fort Lauderdale, Fla.

• share
• favorite_border

Certain children who wear a special kind of no-line bifocal lenses show signs of slower progression of myopia than those who wear more conventional lenses according to a new study published in the February 2007 issue of Investigative Ophthalmology & Visual Science (IOVS).